Screening Filters
Market Cap ≥ $10B ('market_cap': {'min': '10000000000'})
- Purpose: Focus on large, established healthcare companies.
- Rationale: When someone asks for “top stocks,” that typically implies leaders in their space, not small or speculative names. A $10B+ market cap filter ensures we’re looking at well-capitalized, usually more stable and widely followed companies.
Sector = Healthcare ('sector': ['Healthcare'])
- Purpose: Restrict results to the overall healthcare sector.
- Rationale: This is the direct translation of “health sector.” It excludes non-healthcare companies and keeps only those whose primary business is health-related.
Specific Healthcare Industries
('industry': ['Biotechnology & Medical Research', 'Healthcare Equipment & Supplies', 'Healthcare Providers & Services', 'Pharmaceuticals'])
- Purpose: Target the main investable segments within healthcare.
- Rationale:
- Biotechnology & Medical Research: innovation and drug discovery.
- Pharmaceuticals: established drug manufacturers.
- Healthcare Equipment & Supplies: makers of devices, tools, and consumables used in care.
- Healthcare Providers & Services: hospitals, clinics, insurers, and service platforms.
Together, these capture the core of the “health sector” rather than fringe or loosely related industries.
Major U.S. Exchanges Only
('list_exchange': ['XNYS', 'XNAS', 'XASE'])
- Purpose: Limit to companies listed on NYSE, NASDAQ, and NYSE American.
- Rationale: “Top” stocks are usually those with high liquidity, transparency, and regulatory oversight. These three exchanges host the bulk of prominent U.S.-listed healthcare stocks and are more accessible for most investors.
Return on Equity (ROE) ≥ 10%
('return_on_equity': {'min': '10'})
- Purpose: Filter for companies generating solid profitability relative to shareholder equity.
- Rationale: A 10%+ ROE suggests effective use of capital and generally stronger business quality, aligning with the idea of “top” performers rather than just large but inefficient companies.
5-Year Revenue CAGR ≥ 5%
('revenue_5yr_cagr': {'min': '5'})
- Purpose: Ensure the companies have demonstrated real business growth over time.
- Rationale: Healthcare is a growth-oriented sector. Requiring at least 5% compound annual revenue growth over five years focuses on businesses that are expanding, not just stagnant incumbents.
Analyst Consensus = Strong Buy or Moderate Buy
('analyst_consensus': ['Strong Buy', 'Moderate Buy'])
- Purpose: Incorporate professional analyst sentiment into the selection.
- Rationale: “Top” often implies not just size and fundamentals, but also current market favorability. Limiting to stocks with positive analyst consensus helps surface names that analysts currently view as attractive, based on their models and research.
Why Results Match “Top Stocks in the Health Sector”
- They are clearly within healthcare, across its main subsectors (biotech, pharma, equipment, providers).
- They are large, established players, fitting a common interpretation of “top” (by size and prominence).
- They show solid profitability and multi-year growth, which points to business quality rather than just hype.
- They are positively rated by analysts, adding an external, professional view that these are among the more attractive healthcare names right now.
This list is generated based on data from one or more third party data providers. It is provided for informational purposes only by Intellectia.AI, and is not investment advice or a recommendation. Intellectia does not make any warranty or guarantee relating to the accuracy, timeliness or completeness of any third-party information, and the provision of this information does not constitute a recommendation.